Whalen C M, Hockin J C, Ryan A, Ashton F
Field Epidemiology Division, Bureau of Communicable Disease Epidemiology, Ottawa, Ontario, Canada.
JAMA. 1995 Feb 1;273(5):390-4.
To describe the occurrence of invasive meningococcal disease (IMD) in Canada with respect to demographic variables and characteristics of the isolated strains of Neisseria meningitidis.
National surveillance case series.
Canada, 1985 through 1992.
Morbidity and mortality.
The incidence of IMD averaged 1.38 per 100,000 person-years, with considerable regional variation. In 1988, serogroup C organisms became more common, with one strain of the electrophoretic type 37 (ET-37) complex of N meningitidis, termed ET-15, the predominant group C strain identified. With the increase in group C disease, a greater proportion of cases were older than 5 years. By 1991, ET-15 was the most common strain identified in most parts of the country. Electrophoretic type 15 had a case fatality of 17.8% vs 8.1% for all other IMD (P < .001). Among cases 20 years and older the case fatality for ET-15 was 22.4%.
The group C, ET-15 strain of N meningitidis, first identified in Canada, was more virulent than other prevalent strains during this period. Active surveillance, rapid identification, and typing of N meningitidis will assist public health decision making in the control of emerging strains.
描述加拿大侵袭性脑膜炎球菌病(IMD)在人口统计学变量和脑膜炎奈瑟菌分离菌株特征方面的发生情况。
全国监测病例系列。
加拿大,1985年至1992年。
发病率和死亡率。
IMD的发病率平均为每10万人年1.38例,存在显著的地区差异。1988年,C群菌株变得更为常见,其中一种脑膜炎奈瑟菌电泳型37(ET-37)复合体的菌株,称为ET-15,是鉴定出的主要C群菌株。随着C群疾病的增加,5岁以上病例的比例更大。到1991年,ET-15是该国大部分地区最常见的菌株。电泳型15的病死率为17.8%,而所有其他IMD为8.1%(P<.001)。在20岁及以上的病例中,ET-15的病死率为22.4%。
首次在加拿大鉴定出的脑膜炎奈瑟菌C群ET-15菌株在此期间比其他流行菌株更具毒性。对脑膜炎奈瑟菌进行主动监测、快速鉴定和分型将有助于公共卫生决策以控制新出现的菌株。